Kensington, MD, United States of America

Eduardo Agustin Padlan

This inventor holds 25 USPTO granted patents and 5 EPO patents, primarily in Humanized Antibodies. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Idec Pharmaceuticals Corporation, Biogen Idec, Inc.. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eduardo Agustin Padlan. Retrieved from https://idiyas.com/inventor/eduardo-agustin-padlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 56.0

EPO Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 3.7

ph-index = 10

Forward Citations = 455(Granted Patents)

Company Filing History:

14 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

3 out of 37

Idec Pharmaceuticals Corporation

Cancer Research Fund of Contra Costa

patents

6. 1 out of 2,198

Smithkline Beecham Corporation

patents

7. 1 out of 7,680

The Dow Chemical Company

patents

8. 1 out of 1,217

The United States of America as Represented by the Department of Health

patents

9. 1 out of 248

University of Vermont

patents

10. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2014

Loading Chart...

Areas of Expertise:

Humanized Antibodies

Anti-CD20 Monoclonal Antibody

Immunogenicity Methods

CC49 Variants

Nucleic Acids Encoding Antibodies

Composite Antibodies

Minimally Immunogenic Variants

Anti-Factor IX/IXa Antibodies

Treating Autoimmune Diseases

Immunoconjugates

Human Gp39 Antibodies

Polynucleotides

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8835167 - Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors (2014-09-16),

2. 8828717 - Framework residue substituted humanized COL-1 antibodies and their use (2014-09-09),

3. 8535890 - Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies (2013-09-17),

4. 8101179 - Anti-CD20 monoclonal antibody (2012-01-24),

5. 8029788 - Variants of humanized anti-carcinoma MAb CC49 (2011-10-04),

6. 7919607 - Nucleic acids encoding humanized anti-tag 72 CC49 antbodies (2011-04-05),

7. 7915396 - Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 (2011-03-29),

8. 7855276 - Framework residue substituted humanized COL-1 antibodies and their use (2010-12-21),

9. 7763719 - Variants of humanized anti-carcinoma MAb CC49 (2010-07-27),

10. 7589181 - Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use (2009-09-15),

11. 7569673 - Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors (2009-08-04),

12. 7256004 - Variants of humanized anti-carcinoma monoclonal antibody CC49 (2007-08-14),

13. 7179899 - Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72 (2007-02-20),

14. 7074406 - Treating allergic diseases with humanized anti-CD40L antibody (2006-07-11),

15. 6818749 - Variants of humanized anti carcinoma monoclonal antibody cc49 (2004-11-16),

Title: The Innovative Mind of Eduardo Agustin Padlan

Introduction: Eduardo Agustin Padlan is a visionary inventor based in Kensington, MD, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Eduardo Agustin Padlan holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Padlan has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Eduardo Agustin Padlan has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eduardo Agustin Padlan's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.